Manas AI raised $24.6 million in a seed round co-led by General Catalyst and Reid Hoffman to transform the discovery of novel cancer medicines.
Manas AI raised $24.6 million in a seed round co-led by General Catalyst and Reid Hoffman to transform the discovery of novel cancer medicines.
01/27/25, 2:09 PM
Location
san franciscoMoney raised
$24.6 million
Industry
artificial intelligence
biotechnology
Round Type
seed
Investors
Greylock, Reid Hoffman, General Catalyst
Manas AI launched with a focus on transforming cancer and rare disease treatments through its AI-driven platform. The company aims to accelerate the development of new medicines, leveraging a partnership with Microsoft and a team of leading scientists.
Company Info
Location
san francisco, california, united states
Additional Info
Manas AI is an AI-driven company focused on discovering and advancing next-generation medicines. Co-founded by Dr. Siddhartha Mukherjee and Reid Hoffman, it integrates generative computational chemistry with AI to transform drug development timelines and costs. The company's mission is to accelerate the discovery and development of life-saving medicines, particularly for cancer and rare diseases. Its partnership with Microsoft leverages cloud computing and AI to enhance therapeutic discovery processes.